This year we are celebrating 25 years of smarter studies, global impact, and better health. '25 at 25' is a series of articles highlighting 25 of our major achievements.
Latest News
'25 at 25': Defining treatment for ovarian cancer
In this article in our series celebrating 25 years of smarter studies, global impact and better health, we look at how the MRC CTU at UCL has helped define treatment for ovarian cancer.
08 Oct
Our methodology research at ICTMC 2024
MRC CTU at UCL methodology researchers will have a large turnout at the 7th International Clinical Trials Methodology Conference in Edinburgh, UK.
26 Sep
New podcast episode: Preventing multidrug-resistant tuberculosis
In this episode of the Trial Talk podcast, we find out more about the TB-CHAMP and VQUIN trials, and how the teams came together to combine their data and strengthen their evidence.
23 Sep
No clear evidence that adding diabetes drug to standard prostate cancer treatment reduces risk of death, but side effects of hormone therapy lessened
New results from the STAMPEDE trial metformin comparison were presented at the 2024 ESMO Congress.
16 Sep
Research Themes
Cancer
Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types
Infections
Major international clinical trials answering questions of global public health significance
Neurodegenerative diseases
New generation of innovative multi-arm multi-stage trials to identify and test new therapeutic treatments in neurodegenerative diseases (NDD)
Methodology
Development of methods with direct impact on the design, conduct and analysis of studies
Other Research & Policy
This section will capture projects outside the current QQR themes